(Q39334033)

11 September 2017

title

miR-376a suppresses proliferation and induces apoptosis in hepatocellular carcinoma (English)

1 reference

11 September 2017

0 references

Yongxia Zheng

1

1 reference

11 September 2017

Lei Yin

2

1 reference

11 September 2017

Huan Chen

3

1 reference

11 September 2017

Shengsheng Yang

4

1 reference

11 September 2017

Chuanyong Pan

5

1 reference

11 September 2017

Shan Lu

6

1 reference

11 September 2017

Mingyong Miao

7

1 reference

11 September 2017

Binghua Jiao

8

1 reference

11 September 2017

language of work or name

English

0 references

publication date

7 June 2012

1 reference

11 September 2017

1 reference

11 September 2017

volume

586

1 reference

11 September 2017

issue

16

1 reference

11 September 2017

page(s)

2396-2403

1 reference

MicroRNAs: genomics, biogenesis, mechanism, and function

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.05.054

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.05.054

DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.05.054

Cancer gene discovery in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.05.054

Molecular classification and novel targets in hepatocellular carcinoma: recent advancements

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.05.054

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.05.054

The role of signaling pathways in the development and treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.05.054

Inhibition of PI3K/Akt signaling: an emerging paradigm for targeted cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.05.054

PI3K/Akt signalling pathway and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.05.054

Phosphoinositide 3-OH kinase p85alpha and p110beta are essential for androgen receptor transactivation and tumor progression in prostate cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.05.054

Growth of hepatocellular carcinoma in the regenerating liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.05.054

Liver regeneration associated protein (ALR) exhibits antimetastatic potential in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.05.054

Comparison of gene expression in hepatocellular carcinoma, liver development, and liver regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.05.054

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.05.054

Comprehensive analysis of human microRNA target networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.05.054

Why do hubs tend to be essential in protein networks?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.05.054

Inhibitory effects of adenovirus mediated Akt1 and PIK3R1 shRNA on the growth of malignant tumor cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.05.054

The role of microRNAs in human liver cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.05.054

New concepts in liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.05.054

Genomewide microRNA down-regulation as a negative feedback mechanism in the early phases of liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.05.054

Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.05.054

Regulation of erythroid differentiation by miR-376a and its targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.05.054

Relationship between serum alpha-foetoprotein, cirrhosis and survival in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.05.054

High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.05.054

Experimental strategies for microRNA target identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.05.054

Desperately seeking microRNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.05.054

Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.05.054

Suppression of the PI3K subunit p85α delays embryoid body development and inhibits cell adhesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.05.054

miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.05.054

10.1016/J.FEBSLET.2012.05.054

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference